Investment Summary |
|
|---|---|
| Date | 2010-01-15 |
| Target | Anesiva |
| Sector | Life Science |
| Sellers(s) |
EGS Healthcare Capital Partners
Alta Partners |
| Deal Type | Bankruptcy |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 135M USD |
| Size | Small |
| Type | Sector Focused |
EGS Healthcare Capital Partners is a specialist private equity firm focused on investments in the healthcare sector. Specific areas of interest include biotechnology, specialty pharmaceutical, and medical device companies. EGS typically invests in late-stage private and emerging public companies with promising products. EGS prefers to lead investments with an initial commitment of $5 million per transaction. The Firm generally seeks board representation. EGS Healthcare Partner was formed in 1999 and is based in Rowayton, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 7 |
| Sector: Life Science M&A | 5 of 5 |
| Type: Bankruptcy M&A Deals | 1 of 1 |
| State: California M&A | 3 of 3 |
| Country: United States M&A | 6 of 6 |
| Year: 2010 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-06-01 |
Jazz Pharmaceuticals
Dublin, Ireland Jazz Pharmaceuticals is a specialty biopharmaceutical company that identifies, develops, and commercializes products to address unmet medical needs in focused therapeutic areas. Jazz Pharmaceuticals was founded in 2003 and is based in Dublin, Ireland. |
Sell | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 42 of 85 |
| Sector: Life Science M&A | 28 of 65 |
| Type: Bankruptcy M&A Deals | 1 of 5 |
| State: California M&A | 20 of 41 |
| Country: United States M&A | 35 of 75 |
| Year: 2010 M&A | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-12-08 |
Coapt Systems
Palo Alto, California, United States Coapt Systems is developing and commercializing products for soft tissue surgery and fixation. The Company’s initial products are targeting the aesthetic facial surgery market. Coapt Systems was founded in 2000 and is based in Palo Alto, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-07 |
Achaogen
San Francisco, California, United States Achaogen is a bio-pharmaceutical company developing treatments for life-threatening infections caused by multi-drug resistant (MDR) Gram-negative bacteria, an area of critical unmet medical need. Achaogen was formed in 2002 and is based in San Francisco, California. |
Buy | - |
